KONINKLIJKE PHILIPS NV (PHI1.DE) Stock Fundamental Analysis

Europe • Frankfurt Stock Exchange • FRA:PHI1 • NL0000009538

24.15 EUR
-0.1 (-0.41%)
Last: Jan 30, 2026, 07:00 PM
Fundamental Rating

3

PHI1 gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 68 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of PHI1 have multiple concerns. PHI1 is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • In the past year PHI1 was profitable.
  • PHI1 had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: PHI1 reported negative net income in multiple years.
  • PHI1 had a positive operating cash flow in 4 of the past 5 years.
PHI1.DE Yearly Net Income VS EBIT VS OCF VS FCFPHI1.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B

1.2 Ratios

  • The Return On Assets of PHI1 (0.63%) is worse than 62.50% of its industry peers.
  • PHI1's Return On Equity of 1.56% is on the low side compared to the rest of the industry. PHI1 is outperformed by 62.50% of its industry peers.
  • PHI1 has a Return On Invested Capital of 3.95%. This is in the lower half of the industry: PHI1 underperforms 60.94% of its industry peers.
Industry RankSector Rank
ROA 0.63%
ROE 1.56%
ROIC 3.95%
ROA(3y)-3.08%
ROA(5y)1.15%
ROE(3y)-7.29%
ROE(5y)2.23%
ROIC(3y)N/A
ROIC(5y)N/A
PHI1.DE Yearly ROA, ROE, ROICPHI1.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

  • The Profit Margin of PHI1 (0.93%) is worse than 62.50% of its industry peers.
  • PHI1 has a Operating Margin (6.10%) which is comparable to the rest of the industry.
  • In the last couple of years the Operating Margin of PHI1 has declined.
  • Looking at the Gross Margin, with a value of 43.49%, PHI1 is doing worse than 76.56% of the companies in the same industry.
  • PHI1's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 6.1%
PM (TTM) 0.93%
GM 43.49%
OM growth 3Y-1.59%
OM growth 5Y-8.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y1.08%
PHI1.DE Yearly Profit, Operating, Gross MarginsPHI1.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

2

2. Health

2.1 Basic Checks

  • PHI1 has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, PHI1 has less shares outstanding
  • Compared to 5 years ago, PHI1 has more shares outstanding
  • The debt/assets ratio for PHI1 is higher compared to a year ago.
PHI1.DE Yearly Shares OutstandingPHI1.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
PHI1.DE Yearly Total Debt VS Total AssetsPHI1.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

  • PHI1 has an Altman-Z score of 1.97. This is not the best score and indicates that PHI1 is in the grey zone with still only limited risk for bankruptcy at the moment.
  • With a Altman-Z score value of 1.97, PHI1 perfoms like the industry average, outperforming 42.19% of the companies in the same industry.
  • The Debt to FCF ratio of PHI1 is 14.51, which is on the high side as it means it would take PHI1, 14.51 years of fcf income to pay off all of its debts.
  • PHI1's Debt to FCF ratio of 14.51 is on the low side compared to the rest of the industry. PHI1 is outperformed by 60.94% of its industry peers.
  • PHI1 has a Debt/Equity ratio of 0.69. This is a neutral value indicating PHI1 is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.69, PHI1 is doing worse than 71.88% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF 14.51
Altman-Z 1.97
ROIC/WACC0.6
WACC6.61%
PHI1.DE Yearly LT Debt VS Equity VS FCFPHI1.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

2.3 Liquidity

  • A Current Ratio of 1.32 indicates that PHI1 should not have too much problems paying its short term obligations.
  • PHI1 has a Current ratio (1.32) which is in line with its industry peers.
  • A Quick Ratio of 0.86 indicates that PHI1 may have some problems paying its short term obligations.
  • PHI1's Quick ratio of 0.86 is on the low side compared to the rest of the industry. PHI1 is outperformed by 65.63% of its industry peers.
Industry RankSector Rank
Current Ratio 1.32
Quick Ratio 0.86
PHI1.DE Yearly Current Assets VS Current LiabilitesPHI1.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B

4

3. Growth

3.1 Past

  • PHI1 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 15.15%, which is quite good.
  • Measured over the past years, PHI1 shows a decrease in Earnings Per Share. The EPS has been decreasing by -7.17% on average per year.
  • PHI1 shows a decrease in Revenue. In the last year, the revenue decreased by -1.43%.
  • Measured over the past years, PHI1 shows a small growth in Revenue. The Revenue has been growing by 1.00% on average per year.
EPS 1Y (TTM)15.15%
EPS 3Y-5.66%
EPS 5Y-7.17%
EPS Q2Q%12.5%
Revenue 1Y (TTM)-1.43%
Revenue growth 3Y1.65%
Revenue growth 5Y1%
Sales Q2Q%-1.71%

3.2 Future

  • PHI1 is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.28% yearly.
  • PHI1 is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.00% yearly.
EPS Next Y4.94%
EPS Next 2Y4.81%
EPS Next 3Y7.44%
EPS Next 5Y10.28%
Revenue Next Year-2.27%
Revenue Next 2Y0.25%
Revenue Next 3Y1.58%
Revenue Next 5Y3%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
PHI1.DE Yearly Revenue VS EstimatesPHI1.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B 25B
PHI1.DE Yearly EPS VS EstimatesPHI1.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5 2

4

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 16.32, PHI1 is valued correctly.
  • Based on the Price/Earnings ratio, PHI1 is valued cheaper than 93.75% of the companies in the same industry.
  • PHI1's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 28.32.
  • Based on the Price/Forward Earnings ratio of 15.87, the valuation of PHI1 can be described as correct.
  • 75.00% of the companies in the same industry are more expensive than PHI1, based on the Price/Forward Earnings ratio.
  • The average S&P500 Price/Forward Earnings ratio is at 25.57. PHI1 is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 16.32
Fwd PE 15.87
PHI1.DE Price Earnings VS Forward Price EarningsPHI1.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of PHI1 indicates a somewhat cheap valuation: PHI1 is cheaper than 70.31% of the companies listed in the same industry.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as PHI1.
Industry RankSector Rank
P/FCF 40.23
EV/EBITDA 12.79
PHI1.DE Per share dataPHI1.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)3.3
PEG (5Y)N/A
EPS Next 2Y4.81%
EPS Next 3Y7.44%

0

5. Dividend

5.1 Amount

  • No dividends for PHI1!.
Industry RankSector Rank
Dividend Yield 0%

KONINKLIJKE PHILIPS NV / PHI1.DE FAQ

What is the ChartMill fundamental rating of KONINKLIJKE PHILIPS NV (PHI1.DE) stock?

ChartMill assigns a fundamental rating of 3 / 10 to PHI1.DE.


What is the valuation status for PHI1 stock?

ChartMill assigns a valuation rating of 4 / 10 to KONINKLIJKE PHILIPS NV (PHI1.DE). This can be considered as Fairly Valued.


How profitable is KONINKLIJKE PHILIPS NV (PHI1.DE) stock?

KONINKLIJKE PHILIPS NV (PHI1.DE) has a profitability rating of 2 / 10.


How financially healthy is KONINKLIJKE PHILIPS NV?

The financial health rating of KONINKLIJKE PHILIPS NV (PHI1.DE) is 2 / 10.


Can you provide the dividend sustainability for PHI1 stock?

The dividend rating of KONINKLIJKE PHILIPS NV (PHI1.DE) is 0 / 10 and the dividend payout ratio is 199.39%.